Buy Tesamorelin Ipamorelin Peptide Blend 7mg Online in USA

Tesamorelin / Ipamorelin Peptide Blend 7mg

One vial 5 mg / 2 mg was $85 now $60

Compound: Tesamorelin and Ipamorelin Peptide Blend

Concentration: 7mg Total (5mg Tesamorelin + 2mg Ipamorelin)

Format: Lyophilized White Powder (Strictly for In-Vitro Laboratory Use)

Chemical Classification: GHRH Analog + Selective GH Secretagogue

Chemical Profile: This formulation combines two distinct peptide classes to investigate the synergistic stimulation of the somatotropic axis.

Tesamorelin: A stabilized analogue of Growth Hormone Releasing Hormone (GHRH) that binds to GHRH receptors in the anterior pituitary. It is noted for its high specificity and ability to significantly elevate Insulin-Like Growth Factor 1 (IGF-1) levels without altering glucose homeostasis.
Ipamorelin: A selective ghrelin receptor agonist (GH-Secretagogue) that mimics the hunger hormone ghrelin to stimulate GH release. Unlike older generation secretagogues (e.g., GHRP-6), Ipamorelin does not stimulate the release of adrenocorticotropic hormone (ACTH), cortisol, prolactin, or aldosterone.

By combining a GHRH analog (which increases the amount of GH secreted per pulse) with a GH Secretagogue (which initiates the pulse itself), this blend offers a unique model for studying maximal physiological output without the negative feedback loops associated with single-agent saturation.

Monthly subscription five vials of 5 mg /2 mg for a total of 25 mg / 10 mg was $600 now $450

Visceral Adipose Tissue (VAT) & Lipid Profiles Tesamorelin is the primary subject of research regarding the specific reduction of Visceral Adipose Tissue (VAT). Preclinical studies have demonstrated its ability to reduce liver fat and triglycerides. When combined with Ipamorelin’s lipolytic properties, this blend is utilized to model the acceleration of lipid oxidation and the reduction of Carotid Intima-Media Thickness (CIMT), a key marker of cardiovascular health.
Cognitive Function & Nootropic Models Research indicates that GHRH analogs like Tesamorelin may influence cognitive retention and executive function. Current studies are exploring the application of this peptide in models of mild cognitive impairment (MCI) to observe potential neuroprotective effects against progression to neurodegenerative states. The addition of Ipamorelin allows for the study of how GH pulsatility impacts synaptic plasticity.
Inflammation & C-Reactive Protein (CRP) In laboratory trials, Tesamorelin administration has been correlated with a decrease in C-Reactive Proteins (CRP), a systemic marker of inflammation. Researchers utilize this blend to investigate the immunomodulatory effects of the GH/IGF-1 axis and its role in reducing chronic low-grade inflammation associated with metabolic syndrome.
Sleep Architecture & Recovery Ipamorelin is well-documented for its influence on Slow-Wave Sleep (SWS) or “deep sleep” phases. This blend is frequently used in neurological research to observe how enhanced GH pulsatility during sleep cycles affects physical recovery, neural repair, and circadian rhythm regulation in aging models.
Synergistic Metabolic Modulation The dual-action mechanism of this blend allows researchers to study “amplified” metabolic effects. By stimulating the pituitary via two separate receptors (GHRH-R and GHS-R1a), this combination is used to model the restoration of youthful metabolic function, including improved nitrogen retention and insulin sensitivity, without the side effects of non-selective agonists.

Disclaimer: This product is sold explicitly as a chemical reagent for laboratory research and testing purposes only. It is not intended for human consumption, diagnostic, or therapeutic use. Bodily introduction of any kind into humans or animals is strictly forbidden by law.